Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 543-551

  Cavazzana Calvo, M ^a,b   Bensoussan, D ^a   Jabado, N ^b   Haddad, E ^b   Yvon, E ^a   Moskwa, M ^a   Tachet Des Combes, A ^b   Buisson, M ^c   Morand, P ^c   Virion, J M ^d   Le Deist, F ^b   Fischer, A ^b  

^a Etablissement Transfus Sang l'A   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

B cell depletion; EBV lymphoproliferative disorder; Mismatched BMT; Prevention of BLPD

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CD2 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY CD 2; MONOCLONAL ANTINODY LFA 1; THIOTEPA; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; INFANT; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL RATE;

B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; RETROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING;

EID: 7844222081     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00972.x     Document Type: Article

References (42)

1. Ash, R.C., Casper, J.T., Chitambar, C.R., Hansen, R., Bunin, N., Truitt, R., Lauton, C., Murray, K., Hunter, J., Baxter-Lowe, L.A., Gottschall, J., Oldham, K., Anderson, T., Camitta, B. & Menitove, J. (1990) Successful allogenic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors. New England Journal of Medicine, 8, 485-494.
2. Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M.P., Gambelunghe, C., Rossetti, M., Caputo, P.F., Latini, P., Aristei, C., Raymondi, C., Reisner, Y. & Martelli, M. (1994) Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by adding of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood. 84, 3948-3955.
3. Beatty, P.G., Clift, R.A., Mickelson, E.M., Nisperos, B., Flournoy, N., Martin, P., Sanders, J., Stewart, P., Buckner, D., Storb, R., Thomas, D. & Hansen, J. (1985) Marrow transplantation from related donors other than HLA identical siblings. New England Journal of Medicine, 13, 765-771.
4. Beatty, P.G., Dahlberg, S., Mickelson, E.M., Nisperos, B., Opelz, G., Martin, P.J. & Hansen, J.A. (1988) Probability of finding HLA-matched unrelated marrow donors. Transplantation, 45, 714-718.
5. Benkerrou, M., Durandy, A. & Fischer, A. (1995) Therapy for transplanted lymphoproliferative diseases. Hematology/Oncology Clinics of North America, 7, 467-475.
6. Blanche, S., Le Deist, F., Weber, F., Lenoir, G., Fischer, A.M., Brochier, J., Boucheix, C., Delage, M., Griscelli, C. & Fischer, A. (1988) Treatment of severe Epstein Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Annals of Medicine, 108, 199-203.
7. Blazar, B.R., Korngold, R. & Vallera, D.A. (1997) Recent advances in graft-versus-host disease (GVHD) prevention. Immunological Reviews, 157, 79-109.
8. Bortin, M.M. & Rimm, A.A. (1986) Increasing utilization of bone marrow transplantation. Transplantation, 42, 229-234.
9. Cavazzana-Calvo, M., Bordigoni, P., Michel, G., Esperou, H., Souillet, G., Leblanc, T., Stephan, J.L., Vannier, J.P. Mechinaud, F., Reiffers. J., Vilmer, E., Landman-Parker, J., Benkerrou, M., Baruchel, A., Pico, J., Bernaudin, F., Bergeron, C.. Plouvier, E., Thomas, C., Widjenes, J., Lacour, B., Blanche, S. & Fischer, A. (1996) A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. British Journal of Haematology, 93, 131-138.
10. Coulombel, L., Eaves, A.C. & Eaves, C.J. (1983) Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood. 62, 291-297.
11. Fischer, A., Blanche, S., Le Bidois, J., Bordigoni, P., Garnier, J.L., Niaudet, P., Morinet, F., Le Deist, F., Fischer, A.M., Griscelli, C. & Hirn, M. (1991) Anti-B-cells monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. New England Journal of Medicine, 324, 1451-1456.
12. Fogh, J. (1978) Cultivation, characterization and identification of human tumor cells with emphasis on kidney, testis and bladder tumors. National Cancer Institute Monograph, 49, 5-9.
13. Forman, S.J. & Zaia, J.A. (1994) Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood, 83, 2392-2398.
14. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
15. Goodrich, J.M., Boeckh, M. & Bowden, R. (1994) Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clinical Infectious Disease, 19, 287-298.
16. Hale. F. & Waldmann, H. (1994) Control of graft versus host disease and graft rejection by T-cell depletion of donor and recipient with CAMPATH-1 antibodies: results of matched sibling transplants for malignant diseases. Bone Marrow Transplantation, 13, 597-611.
17. Hale, G. & Waldmann, H. (1996) Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplantation, 17, 305-308.
18. Hansen, J.A., Clift, R.A., Thomas, E.D., Buckner, C.D., Storb, R. & Giblett, E.R. (1980) Transplantation of marrow from an unrelated donor to a patient with acute leukemia. New England Journal of Medicine, 303, 565-567.
19. Hervé, P., Widjenes, J., Bergerat, J.P., Bordigoni, P., Milpied, N., Cahn, J.Y., Clément, C., Béliard, R., Morel-Fourrier, B., Racadot, E., Troussard, X., Benz-Lemoine, E., Gaud, C., Legros, M., Attal, M., Kloft, M. & Peters. A. (1990) Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of antiinterleukin-2 receptor monoclonal antibody (B-B10). Blood, 75, 1017-1023.
20. Heslop, H., Brenner, M. & Rooney. C. (1994) Clinical protocol: administration of neomycin resistance gene marked EBV specific cytotoxic lymphocytes to recipients of mismatched related or phenotipically similar unrelated donor marrow grafts. Human Gene Therapy, 5. 384-397.
21. Jabado, N., Le Deist, F., Cant, A., De Graeff-Meeders, E.R., Fasth, A., Morgan, G., Vellodi, A., Hale, G., Bujan, W., Thomas, C., Cavazzana-Calvo. M., Widjenes. J. & Fischer, A. (1996) Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics. 98, 420-428.
22. Keever, C., Small, T., Flomenberg, N., Heller, G., Pelke, K., Black, P., Pecora, A., Gillio, A., Kernan, N.A. & O'Reilly, R.J. (1989) Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood, 73, 1340-1350.
23. Kernan. N., Bartch, G., Ash, R., Beatty, P., Champlin, R., Filipovich, A. Gajewski, J., Hansen. J., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H., Phillips, G., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K. (1993) Retrospective analysis of 462 unrelated marrow transplants facilitated by The National Marrow Donor Program (NMDP) for treatment of acquired and congenital disorders of the lymphohematopoietic system and congenital metabolic disorders. New England Journal of Medicine, 328, 593-602.
24. Kernan, N., Collins, N.H., Juliano, L., Cartagena, T., Dupont, B. & O'Reilly, R.J. (1986) Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft versus-host disease. Blood, 68, 770-773.
25. Klein, C., Philippe, N., Le Deist, F., Fraitag, S., Prost, C., Durandy, A., Fischer, A. & Griscelli, C. (1994) Partial albinism with immunodeficiency (Griscelli syndrome). Journal of Pediatrics. 125, 886-895.
26. Koehler, M., St. George, K., Ehrlich, G., Mirro, J., Neudorf, S.M. & Rinaldo, C. (1997) Prevention of CMV disease in allogenic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy, Journal of Pediatric Hematology and Oncology. 19, 43-47.
27. Nakahori, Y., Miatani, K., Yamda, M. & Nakagome, Y. (1986) A human chromosome specific repeated DNA family (DY21) consists of a tandem assay pentanucleatides. Nucleic Acids Research, 14, 7569-7571.
28. Papadopoulos, E., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A. & O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 1185-1191.
29. Przepiorka, D., Ippoliti, C., Khouri, I., Woo, M., Mehra, R., Le Bherz, D., Giralt, S., Gajewski, J., Fischer, H., Fritsche, H., Deissoroth, A.B., Cleary, K., Champlin, R., Van Besien, K., Andersson, B., Mahler, R. & Fitzsimmons, W. (1996) Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood, 88, 4383-4389.
30. Rooney, C., Loftin, S., Holladay, M., Brenner, M., Krance, R. & Heslop, H. (1995) Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. British Journal of Haematology. 89, 98-103.
31. Ronx, H., Helg, C., Dumont-Girard, F., Chapuis, B., Jeannet, M. & Roosnek, E. (1996) Analysis of T-cell repopulation after allogenic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood, 87, 3984-3992.
32. Schmidt, G.M., Horak, D.A., Niland, J.C., Duncan, S.R., Forman, S.J., Zaia, J.A., and the City of Hope-Stanford-Syntex CMV Study Group (1991) A randomized, controlled trial of prophylactic gancyclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. New England Journal of Medicine, 324, 1005-1011.
33. Shapiro, R.S., Chauvenet, A., McGuire, W., Pearson, A., Craft, A., McGlave, P. & Filipovich, A. (1988a) Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gammaglobulin. New England Journal of Medicine, 318, 1334.
34. Shapiro, R.S., McClain, K., Frizzera, G., Gajl-Peczalska, K.J., Kersey, J.H., Blazar, B.R., Arthur, D. Patton, D., Greenberg, J., Burke, B., Ramsay, N., McGlave, P. & Filipovich, A. (1988b) Epstein Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 1234-1243.
35. Shimazaki, C., Wisniewski, D.A., Scheinberg, P., Atzpodien, J., Strite, A., Gulati, S., Fried, J., Wisniewolski, R., Wang, C.Y. & Clarkson, B.D. (1988) Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads. Blood, 72, 1248-1252.
36. Socie, G., Landman. J., Gluckman, E., Devergie, A., Raynal, B., Esperou, H. & Brison, O. (1992) Short-term study of chimaerism after bone marrow transplantation for severe aplastic anaemia. British Journal of Haematology, 80, 391-398.
37. Spencer, A., Szydlo, R.M., Brookes, P.A., Kaminski, K., Rule, S., Van Rhee, F., Ward, K.N., Hale, G., Waldmann, H., Hows, J.M., Batchelor, J.R. & Goldman, J. (1995) Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood, 86, 3590-3597.
38. Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. Journal of Immunology, 126, 1614-1619.
39. Thomas, E.D. (1983) Karnofski memorial lecture: marrow transplantation for malignant disease. Journal of Clinical Oncology, 1, 517-531.
40. Wang, F.Z., Dahl, H., Linde, A., Brytting, M., Ehrnst, A. & Ljungman, P. (1996) Lymphotropic herpesviruses in allogenic bone marrow transplantation. Blood, 88, 3615-3620.
41. Westoff, C. (1986) Fertility in the United States, Science, 234, 557- 559.
42. Zutter, M.M., Martin, P.J., Sale, G.E., Shulman, H.M. & Fisher, L., Thomas, E.D. & Durnam, D.M. (1988) Epstein-Barr virus lymphoproliferation after hone marrow transplantation. Blood, 72, 520-529.